Corporate
Vanda Pharma's NEREUS Becomes First New Motion Sickness Drug in 40 Years — Shares Surge 18%
Dec 31, 2025
You're signed outSign in or to get full access.
Leadership at Vanda Pharmaceuticals
Browse executives, board members, and key leadership.
Executives at Vanda Pharmaceuticals
Mihael Polymeropoulos
President and Chief Executive Officer
CEO
Executive
Board
Gunther Birznieks
Senior Vice President, Business Development
Executive
Joakim Wijkstrom
Senior Vice President, Chief Marketing Officer
Executive
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Executive
Timothy Williams
Senior Vice President, General Counsel and Secretary
Executive